| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.2M | +65.3% |
| R&D Expense | $7.4M | +9.6% |
| SG&A Expense | $39.9M | +56.7% |
| Operating Income | -$102.7M | -70.9% |
| Interest Expense | $1.2M | +364.9% |
| Net Income | -$98.0M | -65.5% |
| EPS (Basic) | -$0.44 | -46.7% |
| EPS (Diluted) | -$0.44 | -46.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $237.1M | +480.7% |
| Short-term Investments | $167.4M | -39.2% |
| Accounts Receivable | $476K | -51.3% |
| Inventory | $6.3M | +130.7% |
| Current Assets | $415.4M | +18.1% |
| Total Assets | $700.7M | +5.1% |
| Current Liabilities | $25.4M | -22.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.6M | -20.8% |
| Capital Expenditures | $75.8M | -20.1% |
| Investing Cash Flow | $93.4M | +122.7% |
| Financing Cash Flow | $138.6M | -73.0% |
| Free Cash Flow | -$128.4M | +7.2% |
| Long-term Debt |
| $67.5M |
| +0.9% |
| Total Liabilities | $95.3M | -20.1% |
| Stockholders' Equity | $605.5M | +10.6% |